Advanced company searchLink opens in new window

SHIRE PHARMACEUTICAL CONTRACTS LIMITED

Company number 02024595

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
19 Feb 2024 CH01 Director's details changed for Ms Seyda Atadan Memis on 1 September 2023
19 Dec 2023 AA Full accounts made up to 31 March 2023
07 Jul 2023 CS01 Confirmation statement made on 28 June 2023 with updates
13 Jun 2023 AA Full accounts made up to 31 March 2022
02 Jun 2023 TM02 Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023
10 Mar 2023 PSC02 Notification of Takeda Uk Limited as a person with significant control on 21 December 2022
10 Mar 2023 PSC07 Cessation of Shire Pharmaceuticals Group as a person with significant control on 21 December 2022
26 Jan 2023 TM01 Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023
10 Nov 2022 TM01 Termination of appointment of Mark Gibbons as a director on 8 November 2022
23 Aug 2022 AP01 Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
04 Jul 2022 CS01 Confirmation statement made on 28 June 2022 with updates
19 May 2022 AA Full accounts made up to 31 March 2021
21 Mar 2022 AP01 Appointment of Peter Michael Grubin as a director on 1 March 2022
21 Mar 2022 TM01 Termination of appointment of Kentaro Shirahata as a director on 1 March 2022
11 Nov 2021 SH19 Statement of capital on 11 November 2021
  • GBP 1
11 Nov 2021 CAP-SS Solvency Statement dated 09/11/21
11 Nov 2021 SH20 Statement by Directors
11 Nov 2021 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
09 Jul 2021 CS01 Confirmation statement made on 28 June 2021 with no updates
13 Apr 2021 AA Full accounts made up to 31 March 2020
01 Dec 2020 AP01 Appointment of Mr Kentaro Shirahata as a director on 30 November 2020
01 Dec 2020 AP01 Appointment of Mr Marc Stuart Page as a director on 30 November 2020
01 Dec 2020 TM01 Termination of appointment of Nicholas Hugh Meryon Insall as a director on 30 November 2020
01 Dec 2020 TM01 Termination of appointment of Sarah Lucy Charsley as a director on 30 November 2020
02 Jul 2020 CS01 Confirmation statement made on 28 June 2020 with updates